📋 Tender Overview
The subject of this publication is the conclusion of non-exclusive discount agreements for medicines containing the active ingredient Brivaracetam (ATC Code: N03AX23), limited to the dosage form of film-coated tablets. The contract will be concluded within the framework of an open house model, allowing all interested pharmaceutical companies to participate during the participation period, provided they meet the participation requirements. Individual contract negotiations will not be conducted, and exclusivity is not granted. The purchase quantity is unknown and depends on demand and various factors such as the number of insured individuals and the prescribing behavior of doctors. Brivaracetam, film-coated tablets